This inventor holds 53 USPTO granted patents and 5 published patent applications, plus 13 CIPO patents and 19 EPO patents, primarily in Protein Kinase Inhibitors (CPC class C07D). Top assignees: Astex Therapeutics Limited, Eli Lilly and Company, Otsuka Pharmaceutical Company, Limited. Active years: 2001-2026.
Inventors with similar research interests:
Location History:
- Macclesfield, GB (2001 - 2002)
- Bedfordshire, GB (2010)
- Swavesey, GB (2004 - 2011)
- Cambridge, GB (2006 - 2024)
Company Filing History:
34 out of 125 
10 out of 4,507 
3 out of 846 
Years Active: 2001-2026
Areas of Expertise:
Title: Innovator Spotlight: Christopher William Murray
Introduction:
Christopher William Murray, a prominent inventor based in Cambridge, GB, has made significant contributions to the field of medicine with his innovative patents and groundbreaking research. With an impressive portfolio of 51 patents, Murray has established himself as a leading figure in the development of novel therapeutics.
Latest Patents:
One of Murray's latest patents includes the discovery of Benzolactam compounds as protein kinase inhibitors. These compounds, which are inhibitors of ERK1/2 kinases, have shown promising results in the treatment of ERK1/2-mediated conditions, particularly in combating cancer. The invention of these compounds opens up new possibilities for targeted therapies and cancer treatment.
Career Highlights:
Throughout his career, Christopher William Murray has held key positions at renowned companies such as Astex Therapeutics Limited and Eli Lilly and Company. His expertise and innovative approach have been instrumental in driving forward cutting-edge research initiatives and developing new treatment modalities.
Collaborations:
Murray's collaborative efforts with esteemed coworkers like Valerio Berdini and Gordon Saxty have further enriched his research endeavors. By working closely with talented peers in the field, Murray has been able to leverage diverse perspectives and expertise to push the boundaries of innovation in medicine.
Conclusion:
In conclusion, Christopher William Murray's relentless pursuit of scientific excellence and his passion for innovation have solidified his reputation as a trailblazer in the field of medicine. His groundbreaking patents and collaborative efforts underscore his commitment to advancing medical science and improving patient outcomes. Murray's contributions serve as a testament to the transformative power of innovation in the realm of healthcare.